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INTRODUCTION: Remote cerebellar hemorrhage (RCH) is a rare
phenomenon with only a few hundred cases reported in the literature.
RCH is characterized by spontaneous bleeding in the posterior fossa
following supratentorial craniotomy or spinal surgery. The cause of
RCH is debatable, although a likely theory postulates that large CSF
volume loss leads to "cerebellar sagging," creating changes in infratentorial venous blood pressure resulting in RCH.
METHODS: Seven cases of RCH following surgery were collected
from the Rhode Island Hospital medical records from 2017–2019.
Information on patient demographics, comorbidities, procedures, development of RCH, treatment, complications, and outcomes were collected.
A literature review was completed on PubMed using the keywords
"remote cerebellar hemorrhage" and "postoperative cerebellar hemorrhage."
RESULTS: The cases in this study suggest that CSF loss plays a
direct role in the pathophysiology of a subset of RCH. Three of seven
patients had postoperative changes in CSF dynamics. Of these, two were
presumed to have CNS hypotension resulting from CSF leak after spinal
surgery (lumbar fusion and thoracic laminectomy). One case involved
VP shunt overdrainage which lead to RCH and required suboccipital
craniectomy and adjustment of shunt settings. The other four patients
without postoperative changes in CSF dynamics included patients who
developed RCH following subdural hematoma evacuation. Three of
these patients were asymptomatic and pursued no further treatment.
One was symptomatic but the patient’s family did not pursue further
treatment due to the patient’s age and comorbidities.
CONCLUSION: In summary, CSF dynamics seem to play a key role
in the development of RCH. Our study provides further insight into this
rare condition, and further studies are needed to better understand the
underlying mechanisms of RCH and identify opportunities to prevent
it.
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INTRODUCTION: Stereotactic radiosurgery has been used for
treating cavernous malformation.
R
SRS was
METHODS: Between 1988 and 2018, Gamma Knife
performed in 762 evaluable patients with symptomatic CCMs There
were 262 (34%) CCM in the brainstem, 148 (19%) in basal ganglia or
thalamus, and 372 (49%) in lobar locations. Most patients had experienced 2 or more hemorrhages associated with new neurological deficits.
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The median CM volume was 1.2 cm3 (range, 0.01-28.9), and the median
margin dose was 14.0 Gy.
RESULTS: After SRS, 158 patients (21%) had an imaging confirmed
new hemorrhage at a median follow-up of 49 months. The hemorrhagefree survival after SRS for CCMs was 91% at 1 year, 86% at 3 years,
and 81% at 5 years. The annual hemorrhage rate was 5.6% before and
0.3% after SRS. In univariate analysis, CM volume, brainstem or basal
ganglia or thalamus, and increased number of hemorrhages before SRS
was significantly associated with a higher rate of rehemorrhage after
SRS. In multivariate analysis, number of prior hemorrhages (P < .0001,
HR = 1.31, 95% CI: 1.19-1.47) and lower margin dose (P = .03,
HR = 0.91, 95%CI: 0.85-0.97) were significant. Symptomatic adverse
radiation effects (ARE) developed in 27 patients (3.5%).
CONCLUSION: Patients with an increased rate of hemorrhage
before SRS had an increased risk of rehemorrhage. SRS has proven
especially valuable in patients with deep seated, smaller CCM, and those
with a smaller number of prior bleeds.
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INTRODUCTION: Delayed intraparenchymal hemorrhage(IPH)
after treatment of brain arteriovenous malformations (AVM) is a well
described complication. The underlying mechanism is likely associated
with hemodynamic changes in perinidal tissue. So far, there is no established method to estimate the risk of post-treatment hemorrhage. FLAIR
hyperintense vessels (FHV) are known to be associated with stagnant
blood flow and may reflect hemodynamic changes after AVM treatment.
METHODS: We retrospectively reviewed the medical charts of all
patients that underwent endovascular embolization of a brain AVMs
from July 2017 - January 2020 at a single tertiary care center. Postembolization MR images were evaluated for the presence of FHV and
intraparenchymal hemorrhage.
RESULTS: In total, 50 patients underwent 75 sessions of
embolization, and of those, 53 sessions received post-embolization
MRIs. Post-embolization IPH occurred in 4 cases. FHVs were found
in 100% of those cases (4/4) while only 7% of non-hemorrhage cases
(2/28) demonstrated the presence of FHV (P < .05). Other factors
associated with increased risk of delayed hemorrhage included multiple
sessions of embolization and female sex (P < .05). Patency of the main
draining vein, deep venous drainage, and Spetzler-Martin grade greater
than 2 were not associated with increased risk of hemorrhage (P > .05).
CONCLUSION: Prior studies suggest that FHV likely represents
stagnant or decreased cerebral blood flow. Here, we show that the
presence of FHV is highly correlated with increased risk of postembolization hemorrhage in the treatment of brain AVMs These preliminary results may improve our understanding of the complex pathophysiology of brain AVMs and aid practitioners in the post-operative care
of these patients with the goal of minimizing the risk of delayed intraparenchymal hemorrhage.
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